Loading ETF profile…
This exchange-traded fund endeavors to replicate the financial outcomes of a designated benchmark index, which assesses the investment appreciation of equities within the healthcare sector. It operates under a passive management style, generally utilizing a full replication strategy; however, a sampling approach may be adopted when necessitated by regulatory requirements. The fund's portfolio is comprised of shares from enterprises engaged in providing medical or health-related goods, services, technological innovations, or equipment.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| LLY | Eli Lilly & Co | 14.01% | $2.66B |
| JNJ | Johnson & Johnson | 8.45% | $1.60B |
| ABBV | AbbVie Inc | 6.08% | $1.15B |
| UNH | UnitedHealth Group Inc | 5.45% | $1.03B |
| MRK | Merck & Co Inc | 4.63% | $880.03M |
| TMO | Thermo Fisher Scientific Inc | 2.89% | $548.73M |
| AMGN | Amgen Inc | 2.87% | $544.33M |
| GILD | Gilead Sciences Inc | 2.63% | $500.27M |
| ISRG | Intuitive Surgical Inc | 2.38% | $452.18M |
| ABT | Abbott Laboratories | 2.35% | $446.97M |
| PFE | Pfizer Inc | 2.35% | $446.49M |
| BMY | Bristol-Myers Squibb Co | 1.84% | $350.03M |
| DHR | Danaher Corp | 1.84% | $348.82M |
| CVS | CVS Health Corp | 1.83% | $347.03M |
| VRTX | Vertex Pharmaceuticals Inc | 1.80% | $341.30M |
| SYK | Stryker Corp | 1.66% | $315.28M |
| MDT | Medtronic PLC | 1.50% | $284.14M |
| MCK | McKesson Corp | 1.44% | $272.65M |
| ELV | Elevance Health Inc | 1.33% | $253.29M |
| CI | Cigna Group/The | 1.15% | $219.29M |
| BSX | Boston Scientific Corp | 1.13% | $215.26M |
| REGN | Regeneron Pharmaceuticals Inc | 1.01% | $191.52M |
| HCA | HCA Healthcare Inc | 0.94% | $177.62M |
| EW | Edwards Lifesciences Corp | 0.79% | $149.47M |
| COR | Cencora Inc | 0.79% | $149.24M |